Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Barr buys incontinence product rights

Executive Summary

Barr acquires worldwide rights to Phase II oxybutynin transvaginal ring under an agreement with Schering AG. Barr has been developing the incontinence agent for Schering AG since its acquisition of Enhance Pharmaceuticals in 2002 (1"The Pink Sheet" April 1, 2002, p. 30)...
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

PS043702

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel